Evidence map›Paper›PMID 26223380›Full record

ArticleBMC infectious diseases2015

Temporal trends and clonal diversity of penicillin non-susceptible pneumococci from meningitis cases from 1996 to 2012, in Salvador, Brazil.

Milena Soares dos Santos, Jailton Azevedo, Ana Paula de Oliveria Menezes, Soraia Machado Cordeiro, Eliane Cunegundes Escobar, Josilene Borges Lima, Leila Carvalho Campos, Maria da Glória S Carvalho, Mitermayer G Reis, Albert I Ko and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Genomic surveillance of invasiveMicrobial genomics · 2021
    Article
  4. Article
  5. Article
  6. Evolution of Penicillin Non-susceptibility AmongFrontiers in microbiology · 2019
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Milena Soares dos SantosCentro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz/ Ministério da Saúde, Salvador, Bahia, 40296-710, Brazil. milenasoares25@hotmail.com.
Jailton AzevedoCentro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz/ Ministério da Saúde, Salvador, Bahia, 40296-710, Brazil. jailtinho@yahoo.com.br.
Ana Paula de Oliveria MenezesCentro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz/ Ministério da Saúde, Salvador, Bahia, 40296-710, Brazil. apomenezes2@hotmail.com.
Soraia Machado CordeiroDepartamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal da Bahia, 40170115, Salvador, BA, Brazil. soraiamc@yahoo.com.br.
Eliane Cunegundes EscobarCentro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz/ Ministério da Saúde, Salvador, Bahia, 40296-710, Brazil. eliane.fiocruz@gmail.com.
Josilene Borges LimaInstituto de Ciências da Saúde, Universidade Federal da Bahia, Salvador, Bahia, 40110-902, Brazil. josilene_lima@yahoo.com.br.
Leila Carvalho CamposCentro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz/ Ministério da Saúde, Salvador, Bahia, 40296-710, Brazil. lccampos@bahia.fiocruz.br.
Maria da Glória S CarvalhoCenters for Disease Control and Prevention, Streptococcus Laboratory, Atlanta, GA, 30333, USA. msc8@cdc.gov.
Mitermayer G ReisCentro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz/ Ministério da Saúde, Salvador, Bahia, 40296-710, Brazil. miter@bahia.fiocruz.br.
Albert I KoCentro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz/ Ministério da Saúde, Salvador, Bahia, 40296-710, Brazil. albert.ko@yale.edu.
Joice Neves ReisCentro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz/ Ministério da Saúde, Salvador, Bahia, 40296-710, Brazil. joice@ufba.br.
Universidade Federal da Bahia · BRFundação Oswaldo Cruz · BRCenters for Disease Control and Prevention · USFundação de Amparo à Pesquisa do Estado da Bahia · BRMinistério da Saúde · BRSouthwest Bahia State University · BR

Funding

INTERNATIONAL TRAINING &RESEARCH IN EMERGING INFECTIOUSD43TW000919 · FIC · YALE UNIVERSITY · PI KO, ALBERT ICKSANG · 1997 to 2007
$1.2M
Transmission of Drug-Resistant S. pneumoniae in BrazilR01TW007303 · FIC · FEDERAL UNIVERSITY OF BAHIA · PI PEDREIRA, JOICE N · 2005 to 2009
$260k
FIC NIH HHS D43 TW000919FIC NIH HHS D43 TW00919FIC NIH HHS R01 TW007303
6 · The paper itself

Abstract

backgroundHospital-based surveillance for pneumococcal meningitis has been conducted since January 1996 in the city of Salvador, Brazil. The purpose of this study was to describe the temporal evolution of Penicillin Non-Susceptible Streptococcus pneumoniae (PNSSP) in regards to serotype distributions and clonal diversity recovered from meningitis cases over 17 years.

methodsBroth microdilution was used to identify pneumococcal isolates that were PNSSP (Minimum Inhibitory Concentration > 0.12 μg/ml). The annual incidence rate of meningitis cases was calculated. Serotyping was defined using multiplex polymerase chain reaction assays and quellung reaction. Genetic diversity of PNSSP isolates was assessed using both pulsed-field gel electrophoresis (PFGE) and Multilocus Sequence Typing (MLST) analyses.

resultsA total of 854 cerebrospinal fluid (CSF) culture pneumococcal isolates were tested by broth microdilution method and serotyped. A total of 173 (20.3%) were penicillin non-susceptible (PNSSP) (Minimum Inhibitory concentration ≥ 0.12 μg/ml). The annual incidence of meningitis cases declined from 1.65/100,000 population (1996) to 0.2/100,000 population in 2012 and the rate due to PNSSP declined 82% over the 17-years of surveillance. PNSSP isolates were restricted to 13 serotypes, being the most common ones serotypes 14 (45.1%; 78/173), 23 F (19.1%; 33/173), 6B (14.4%; 25/173), 19 F (9.2%; 16/173) and 19A (5.2%; 9/173). Among the PNSSP isolates, 94% had serotypes represented in the 10-valent conjugate vaccine (PCV10). The predominant serotype 14 clonal groups were identified as PFGE group A/multilocus sequence type 66 (ST66) [35.3% (61/173)] and PFGE group GK/ST156 [4.6% (8/173)], the latter one associated with high level resistance to penicillin and ceftriaxone.

conclusionsOur results show sustained reductions in pneumococcal meningitis cases in the Metropolitan region of Salvador from 1996 to 2012. This might reflect a beneficial impact of conjugate vaccines. Continued surveillance and further studies need to be conducted to better understanding on PCV10 vaccine impact.

Indexed as

Penicillin ResistanceAntigenic VariationBacterial Typing TechniquesBrazilCeftriaxoneChildChild, PreschoolFemaleGenetic VariationHumansIncidenceInfantMaleMeningitis, PneumococcalMicrobial Sensitivity TestsMultiplex Polymerase Chain ReactionCeftriaxonePenicillin GPneumococcal VaccinesVaccines, Conjugate

Identifiers

PMID26223380
PMCPMC4520018
OpenAlexW1818489701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.